Find your next paid study

University of Tennessee Graduate School of MedicineNCT07214012

Actual pay is set by the research site.

Phase 2

A Phase 2 Study of VS-6766 (Dual RAF/MEK Inhibitor) Plus Defactinib (FAK Inhibitor) in Recurrent Gynecological Cancers (DURAFAK)

The purpose of this research is to test the effectiveness and safety of the study drugs (VS-6766 and defactinib), and see what effects (good and bad) these dru…

Endometrioid CancerMucinous Ovarian CancerHigh Grade Serous Ovarian Cancer+2 more

University of OklahomaNCT05512208

~$75 – $2,000

Actual pay is set by the research site.

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

The overall goal of this study is to define the phenotype of Interstitial Lung Disease (ILD), and identify factors that predict radiologic progression in those…

Rheumatoid ArthritisInterstitial Lung Disease

University of Colorado, DenverNCT03297775

Actual pay is set by the research site.

Comparative Effectiveness of an Individualized Model of Hemodialysis Versus Conventional Hemodialysis

This study is to prospectively compare clinical effectiveness between clinically- matched incremental hemodialysis and conventional hemodialysis in patients wi…

End-Stage Kidney Disease

Wake Forest University Health SciencesNCT05828823

Actual pay is set by the research site.

Otitis MediaOtitis Media EffusionOtitis Media Recurrent+5 more

The Role of Osteopathic Manipulative Treatment (OMT) in Children With Recurrent or Chronic Otitis Media Prior to Tympanostomy Tube Surgery: A Randomized Clinical Trial

The goal of this clinical trial is to learn whether osteopathic manipulative treatment, or OMT, can reduce the need for tympanostomy tube surgery in children w…

Amyotrophic Lateral Sclerosis (ALS)

~$10 – $1,125

Actual pay is set by the research site.

Sarah VidalNCT07639775

Phase 1

A Multicenter, Open-label, Single-arm, Dose Escalation and Expansion, Phase I/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SNUG01 in Adult Subjects With Amyotrophic Lateral Sclerosis (ALS)

The goal of this clinical trial is to evaluate the safety, tolerability and preliminary efficacy of SNUG01 in in adult subjects with Amyotrophic Lateral Sclero…

SineuGene Therapeutics Co., Ltd.NCT07169175

~$150 – $4,200

Actual pay is set by the research site.

Phase 1

A Phase 1, Multicenter, Open-label Study to Evaluate the Safety and Preliminary Efficacy of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma and Determine the Recommended Dose for Each Add-on Investigational Component

The purpose of this study is to establish a safe and tolerable dose of arlocabtagene autoleucel (BMS-986393) in combinations with alnuctamab, mezigdomide, iber…

Multiple Myeloma

Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyNCT06121843

~$150 – $4,200

Actual pay is set by the research site.

Phase 1

Examining the Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance

The purpose of this research is to determine the extent to which oculomotor function accurately detects THC-impairment, if cannabis use experience impacts this…

Cannabis UseImpaired DrivingCognitive Impairment

Johns Hopkins UniversityNCT06351540

~$500 – $7,500

Actual pay is set by the research site.

Seroprevalence Study of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

This is a multicenter, non-interventional study to observe the natural progression of the disease and to study the prevalence of pre-existing antibodies to AAV…

Arrhythmogenic Right Ventricular Cardiomyopathy

Tenaya TherapeuticsNCT06311708

~$10 – $1,050

Actual pay is set by the research site.

Foot UlcerFoot Ulcer, Diabetic

Testing the Accuracy and Feasibility of Diabetic Foot Ulcer Imaging

All study procedures will occur during one appointment. The research team will measure the size of the foot ulcer (if one is present) and multiple photos will …

Linnea PolgreenNCT03942081

~$10 – $1,125

Actual pay is set by the research site.

Phase 3

AN OPEN-LABEL STUDY IN PEDIATRIC (<18 YEARS OF AGE), SEVERE HEMOPHILIA A PARTICIPANTS (COAGULATION FACTOR ACTIVITY <1%) WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY ≤2%) WITH OR WITHOUT INHIBITORS COMPARING 12 MONTHS OF HISTORICAL STANDARD TREATMENT TO MARSTACIMAB PROPHYLAXIS

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called marstacimab) for the potential treatment of hemophili…

Hemophilia AHemophilia B

~$50 – $2,250

Actual pay is set by the research site.

PfizerNCT05611801

Substance Use DisordersPregnancy RelatedAlcohol Use Disorder (AUD)+14 more

A Randomized Controlled Trial of the Parent-Child Assistance Program in Oklahoma

The Parent-Child Assistance Program (PCAP) helps mothers who have used alcohol, opioids, or other drugs during pregnancy and their children through the work of…